Zacks Investment Management Novo Nordisk A S Transaction History

Zacks Investment Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$69.3 - $90.95 $69 - $90	1 Added 0.03%	3,095 $214,000
Q4 2024 Feb 13, 2025	SELL	$85.0 - $120.04 $24,650 - $34,811	-290 Reduced 8.57%	3,094 $266,000
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $15,836 - $19,340	133 Added 4.09%	3,384 $402,000
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $36,690 - $43,926	299 Added 10.13%	3,251 $464,000
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $103,641 - $137,958	-1,015 Reduced 25.59%	2,952 $379,000
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $14,220 - $17,082	162 Added 4.26%	3,967 $410,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $176,514 - $387,307	1,941 Added 104.13%	3,805 $346,000
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $779 - $863	5 Added 0.27%	1,864 $301,000
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $246,020 - $295,841	1,859 New	1,859 $295,000

1,744

337M

10.7M

16M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $112B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.